Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact

V Aloush, S Navon-Venezia… - Antimicrobial agents …, 2006 - Am Soc Microbiol
Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …

[PDF][PDF] Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact

V Aloush, S Navon-Venezia… - ANTIMICROBIAL …, 2006 - academia.edu
MATERIALS AND METHODS Hospital setting, data collection, and microbiology. The study
was performed at the Tel-Aviv Sourasky Medical Center, Israel, a 1,200-bed tertiary-care …

Multidrug-Resistant Pseudomonas aeruginosa : Risk Factors and Clinical Impact

V Aloush, S Navon-Venezia, Y Seigman-Igra… - Antimicrobial Agents …, 2006 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p>< jats: italic> Pseudomonas
aeruginosa</jats: italic>, a leading nosocomial pathogen, may become multidrug resistant …

[PDF][PDF] Multidrug-Resistant

S Cabili, Y Carmeli, V Aloush, S Navon-Venezia… - Citeseer
MATERIALS AND METHODS Hospital setting, data collection, and microbiology. The study
was performed at the Tel-Aviv Sourasky Medical Center, Israel, a 1,200-bed tertiary-care …

[引用][C] Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact

V ALOUSH, S NAVON-VENEZIA… - Antimicrobial …, 2006 - pascal-francis.inist.fr
Multidrug-resistant Pseudomonas aeruginosa : Risk factors and clinical impact CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

V Aloush, S Navon-Venezia, Y Seigman-Igra, S Cabili… - 2006 - cabidigitallibrary.org
Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

V Aloush, S Navon-Venezia… - Antimicrobial Agents …, 2006 - europepmc.org
Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …

[引用][C] MULTIDRUG-RESISTANTPSEUDOMONAS AERUGINOSA: RISK FACTORS AND CLINICAL IMPACT

V ALOUSH, VS NAVON, IY SEIGMAN, S CABILI… - 2006 - sid.ir
ALOUSH V., NAVON VENEZIA S., SEIGMAN IGRA Y., CABILI S., CARMELI Y.. MULTIDRUG-
RESISTANTPSEUDOMONAS AERUGINOSA: RISK FACTORS AND CLINICAL IMPACT …

[HTML][HTML] Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact

V Aloush, S Navon-Venezia… - Antimicrobial Agents …, 2006 - ncbi.nlm.nih.gov
Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact

V Aloush, S Navon-Venezia… - Antimicrobial …, 2006 - pubmed.ncbi.nlm.nih.gov
Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …